2020年9月16日 -约翰on & Johnson’s Global Public Health团队与Johnson＆Johnson Innovation（JLABS）今天宣布，今天为您，De La Salle医学和健康科学研究所，TBPeopleukraine和ZMQ Global的医生被选为获奖者抗药性-TB生命线QuickFire挑战.
COVID-19 has caused significant disruptions in care for patients with drug-resistant tuberculosis (DR-TB) around the world, particularly in low- and middle-income countries. The Challenge was designed to help ensure continuity of care for people with DR-TB and build stronger, more resilient TB health systems for the future - starting by supporting community-based organizations at the frontlines of care.
The awardees each pitched innovations and potential solutions that aim to bring care closer to home and overcome treatment barriers facing people with TB around the globe during this time. In connection with our overall致力于支持前线医疗保健工人在19日大流行期间，约翰逊和约翰逊很荣幸能为决赛入围者授予总计20万美元的赠款资金，并在他们扩大创新时为他们提供指导。
- DOCTORS FOR YOU (India)
- 这项总部位于印度的非营利组织的可持续潜在解决方案通过WhatsApp＆Uber风格的交付服务使用远程医疗，继续远程提供关键的DR-TB护理服务，以帮助实现印度国家结核消除计划（NTEP）的目标。
- De La Salle Medical and Health Sciences Institute(The Philippines)
- 菲律宾的卫生工作者开发了这一简单应用程序，可以将其下载到任何智能手机上，并旨在通过允许护理人员查看患者剂量信息来支持治疗依从性。它与异步视频观察到的治疗（fot）技术一起使用。
- TBpeopleUkraine (Ukraine)
- 由结核病幸存者创立的慈善组织TBPeopleukraine团结了受影响的社区和亲自参与TB挑战的人的努力。该团队正在扩大One Impcact移动应用程序，该应用程序旨在通过支持依从性并实施以患者为中心的治疗和护理方法来增强结核病社区的能力。患者可以使用该应用程序报告与TB服务的可用性，可访问性和质量有关的障碍，以及应对COVID-19的挑战。所有提出的案件均在24小时内由呼叫中心代表进行跟进，目的是帮助解决此事。
- ZMQ Global (India)
- 总部位于加拿大蒙特利尔的ZMQ团队在印度和非洲工作，并开发了该患者的积极合规性和治疗工具包（PACT）。该移动解决方案使用视频观察到的治疗（FOT）来赋予依从性报告的患者。将他们与远程健康咨询和紧急护理联系起来；并使用行为改变工具以促进治疗依从性。
The QuickFire Challenges are managed by Johnson & Johnson Innovation – JLABS, with the aim to address today’s greatest health care challenges.
The information in this article, is proprietary or licensed to Johnson & Johnson Innovation LLC, its parent company or any affiliate companies (“JJI”) and is仅出于信息目的. This content is not intended to influence the use, sale, recommendation, or promotion of any products or services of Johnson & Johnson or its affiliates. This article contains information from third parties. Please note that only those third parties that provide this information are responsible for it.
通过提供此信息，JJI不认可这些第三方或本文中提供的任何信息，JJI不对内容或信息概不负责您对此信息的任何使用。
关于约翰on & Johnson’s Global Public Health
Charting a bold new, self-sustainable approach, Johnson & Johnson has established the first fully-dedicated organization within a healthcare company focused on combining innovative R&D, novel access programs & approaches, in-country operations, advocacy and the power of multi-sectoral partnerships to ensure that treatments and technologies are available, affordable and accessible for the world's most under-served populations. Harnessing the extensive resources and expertise from across Johnson & Johnson, its Global Public Health team is placing an unparalleled focus on accelerating the pace of innovation needed – from discovery to delivery – to make TB and HIV history, eliminate intestinal worms, address mental health and wrestle other public health challenges. Learn more atwww.jnj.com/global-public-health并遵循我们@JNJGlobalHealth.
关于Johnson＆Johnson Innovation
ld乐动Johnson＆Johnson Innovation LLC致力于加快全球创新的所有阶段，并在企业家和Johnson＆Johnson的全球医疗保健业务之间建立合作。Johnson＆Johnson Innovation为科学家，企业家和新兴公司提供一站式访问科学和技术专家，他们可以促进约翰逊和约翰逊的药品，医疗设备和消费者公司的合作。在Johnson＆Johnson的创新伞下，我们通过区域创新中心与创新者联系；Johnson＆Johnson Innovation - Jlabs；Johnson＆Johnson Innovation - JJDC，Inc。；我们的业务开发团队旨在创建定制的交易和新颖的合作，以加快创新的发展，以解决患者未满足的需求。JLABS为帮助生命科学创业公司蓬勃发展所需的实验室，专业知识，教育，工具和资源提供，所有这些都是没有附带的。已建立了德克萨斯医疗中心（CDI @ TMC）的Johnson＆Johnson创新创新中心，以加速医疗设备的开发。有关Johnson＆Johnson Innovation的更多信息，请访问：www.jnjinnovation.com.
关于Johnson＆Johnson Innovation- JLABS
约翰逊和约翰逊创新- jlabs(JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators across a broad healthcare spectrum including pharmaceutical, medical device, consumer and health tech sectors to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS, we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS also produces campaigns to seek out the best science called QuickFire Challenges. For more information, visitwww.www.2574design.com或关注@jlabs。
